These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1697594)

  • 21. Synthesis and biological evaluation of bombesin constrained analogues.
    Cristau M; Devin C; Oiry C; Chaloin O; Amblard M; Bernad N; Heitz A; Fehrentz JA; Martinez J
    J Med Chem; 2000 Jun; 43(12):2356-61. PubMed ID: 10882361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A structure function study of C-terminal extensions of bombesin.
    Mervic M; Moody TW; Komoriya A
    Peptides; 1991; 12(5):1149-51. PubMed ID: 1666185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced peptide bond pseudopeptide analogues of substance P. A new class of substance P receptor antagonists with enhanced specificity.
    Qian JM; Coy DH; Jiang NY; Gardner JD; Jensen RT
    J Biol Chem; 1989 Oct; 264(28):16667-71. PubMed ID: 2476445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi.
    Radulovic S; Cai RZ; Serfozo P; Groot K; Redding TW; Pinski J; Schally AV
    Int J Pept Protein Res; 1991 Dec; 38(6):593-600. PubMed ID: 1726427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells.
    Dietrich JB; Hildebrand P; Jeker LB; Pansky A; Eberle AN; Beglinger C
    Regul Pept; 1994 Oct; 53(3):165-73. PubMed ID: 7531356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs.
    Wu JM; Hoang DO; Feldman RI
    Mol Pharmacol; 1995 Apr; 47(4):871-81. PubMed ID: 7723750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology and neurochemistry of bombesin-like peptides.
    Moody TW; Crawley JN; Jensen RT
    Peptides; 1982; 3(3):559-63. PubMed ID: 6181494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (D-Phe12) bombesin and substance P analogues function as central bombesin receptor antagonists.
    Merali Z; Merchant CA; Crawley JN; Coy DH; Heinz-Erian P; Jensen RT; Moody TW
    Synapse; 1988; 2(3):282-7. PubMed ID: 2463692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological profiles of two bombesin analogues in cells transfected with human neuromedin B receptors.
    Ryan RR; Taylor JE; Daniel JL; Cowan A
    Eur J Pharmacol; 1996 Jun; 306(1-3):307-14. PubMed ID: 8813645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bombesin, neuromedin B and neuromedin C interact with a common rat pancreatic phosphoinositide-coupled receptor, but are differentially regulated by guanine nucleotides.
    Sekar MC; Uemura N; Coy DH; Hirschowitz BI; Dickinson KE
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):163-9. PubMed ID: 1720612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conveyance of partial agonism/antagonism to bombesin/gastrin-releasing peptide analogues on Swiss 3T3 cells by a carboxyl-terminal leucine insertion.
    Kull FC; Leban JJ; Landavazo A; Stewart KD; Stockstill B; McDermed JD
    J Biol Chem; 1992 Oct; 267(29):21132-8. PubMed ID: 1400423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of potent bombesin antagonist on exocrine pancreatic secretion in rats.
    Varga G; Reidelberger RD; Liehr RM; Bussjaeger LJ; Coy DH; Solomon TE
    Peptides; 1991; 12(3):493-7. PubMed ID: 1717952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of high affinity bombesin receptor subtype 3 agonists.
    Wu JM; Nitecki DE; Biancalana S; Feldman RI
    Mol Pharmacol; 1996 Nov; 50(5):1355-63. PubMed ID: 8913368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of structural modulation on biological activity of bombesin analogues with (E)-alkene bond.
    Fujimoto K; Doi R; Hosotani R; Wada M; Lee JU; Koshiba T; Ibuka T; Habashita H; Nakai K; Fujii N; Imamura M
    Life Sci; 1997; 60(1):29-34. PubMed ID: 8995529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of C-terminal hydroxamide analogues of bombesin.
    Devin C; Bernad N; Cristau M; Artis-Noel AM; Heitz A; Fehrentz JA; Martinez J
    J Pept Sci; 1999 Apr; 5(4):176-84. PubMed ID: 10323197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GRP-preferring bombesin receptors increase generation of inositol phosphates and tension in rat myometrium.
    Amiot F; Leiber D; Marc S; Harbon S
    Am J Physiol; 1993 Dec; 265(6 Pt 1):C1579-87. PubMed ID: 8279518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinguishing bombesin receptor subtypes using the oocyte assay.
    Shapira H; Wada E; Battey JF; Jensen RT; Coy DH; Kusano K
    Biochem Biophys Res Commun; 1991 Apr; 176(1):79-86. PubMed ID: 1850273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced peptide bond pseudopeptide analogues of secretin. A new class of secretin receptor antagonists.
    Haffar BM; Hocart SJ; Coy DH; Mantey S; Chiang HC; Jensen RT
    J Biol Chem; 1991 Jan; 266(1):316-22. PubMed ID: 1702423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives.
    Cai RZ; Reile H; Armatis P; Schally AV
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12664-8. PubMed ID: 7809097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes.
    Pradhan TK; Katsuno T; Taylor JE; Kim SH; Ryan RR; Mantey SA; Donohue PJ; Weber HC; Sainz E; Battey JF; Coy DH; Jensen RT
    Eur J Pharmacol; 1998 Feb; 343(2-3):275-87. PubMed ID: 9570477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.